Adaptive Biotechnologies Corp (ADPT) › RevenueAdaptive Biotechnologies Corp (ADPT) — RevenueAnnual figures by fiscal year, from SEC filings.2017: $38.45M2018: $55.66M2019: $85.07M2020: $98.38M2021: $154.34M2022: $185.31M2023: $170.28M2024: $178.96M2025: $276.98M$276.98M2017Revenue (USD)2025Fiscal YearRevenueChange YoY2025$276.98M+54.8%2024$178.96M+5.1%2023$170.28M-8.1%2022$185.31M+20.1%2021$154.34M+56.9%2020$98.38M+15.6%2019$85.07M+52.8%2018$55.66M+44.8%2017$38.45M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share